骨质疏松症遗传机制的研究进展
Recent Development in Research of Heredity Mechnism of Osteoporosis
出处
《同济大学学报(医学版)》
CAS
2002年第2期172-175,共4页
Journal of Tongji University(Medical Science)
参考文献16
-
1[1]Barthe N,Basse-Cathalinat B, Meunier P J, et al. Measurement of bone mineral density in mother-daughter pairs for evaluating the family influence on bone mss acquisition: a GRIO survey[J]. Osteoporos Int, 1998,8 ( 4 ): 379-384.
-
2[2]Gennari L, Becherini L, Mansani R, et al. Fok Ⅰ ploymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women[J]. J Bone Miner Res, 1999,14(8): 1379 - 1386.
-
3[3]Luootte G, Mercier G, Burckel A. The vitamin D receptor Fok Ⅰ start codon polymorphism and bone mineral density in osteoporotic postmenopausal French women[J]. Clin Genet, 1999,56(3) :221 - 224.
-
4[4]Fountas L,Moutsatsou P,Kastanias I, et al. The contribution of vitamin D receptor gene polymorphisms in osteoporosis and familial osteoporosis[J]. Osteoporosis Int,1999,10 (5): 392 - 398.
-
5[5]Ogawa S, Fujita M, Ishii Y, et al. Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathways [J]. J Biol Chem, 2000, 275(28) :21372 - 21379.
-
6[6]Ogawa S, Hosoi T, Shiraki M, et al. Association of estrogen receptor beta gene polymorphism with bone mineral density[J]. Biochern Biophys Res Commun, 2000, 269(2) :537 - 541.
-
7[7]Opas EE, Gentile MA, Rossert JA, et al. Parathyroid hormone and prostaglandin E2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-alpha1 (Ⅰ)collagen promoter[J]. Bone, 2000,26 (1): 27 - 32.
-
8[8]Heegaard A, Jorgensen HL, Vestergaard AW, et al Lack of influence of collagen type Ⅰ alpha 1 Spl binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years[J]. Calcif Tissue Int,2000,66(6) :409 - 413.
-
9[9]Tsukamoto K, Yoshida H, Watanabe S, et al. Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women[J]. J Hum Genet, 1999,44(3): 148 -151.
-
10[10]Morioka M, Shimodaira K, Kuwano Y, et al. Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast-like cell (HOS) [J]. Biochem Biophys Res Commun,2000,268(1) :60 - 64.
-
1杨芬分.骨质疏松症的预防[J].柳州医学,2007,20(2):71-73. 被引量:9
-
2张德清,王刚,林元平,罗盛飞,刘经星,段晓文.物理疗法治疗骨质疏松症患者的临床研究[J].中华物理医学与康复杂志,2004,26(3):159-160. 被引量:7
-
3孙洪勋,王乃宏,华伯埙.原发性骨质疏松症研究进展[J].中国中西医结合影像学杂志,2005,3(1):44-47. 被引量:20
-
4赵琳,杨尔麟.骨量峰值影响因素的研究[J].医学综述,2005,11(1):65-67. 被引量:1
-
5吴炳球.预防骨质疏松症的健康教育[J].现代医药卫生,2007,23(4):578-579. 被引量:1
-
6何帅.浅谈骨质疏松症的预防和治疗方法[J].中国疗养医学,2009,18(8):706-707. 被引量:1
-
7常辉,郭静芹.原发性老年骨质疏松症的临床诊断与防治[J].社区医学杂志,2007,5(10S):48-49. 被引量:6
-
8赵凡桂,王文君.雌激素在大脑老化过程中的作用[J].国外医学(老年医学分册),2005,26(6):255-259. 被引量:1
-
9周智广,李霞.原发性骨质疏松症的诊断与治疗[J].中华老年医学杂志,2003,22(6):328-329. 被引量:8
-
10关节疾病及损伤[J].国外科技资料目录(医药卫生),2000(8):117-117.